Get the Stockscreener App
9.87
8.61%
-0.93
After Hours:
9.87
Twelve Seas Investment Co II stock is traded at $9.87, with a volume of 90,353.
It is down -8.61% in the last 24 hours and down -8.61% over the past month.
Twelve Seas Investment Company II does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
See More
Previous Close:
$10.80
Open:
$9.87
24h Volume:
90,353
Relative Volume:
66.00
Market Cap:
$111.75M
Revenue:
-
Net Income/Loss:
$3.55M
P/E Ratio:
129.36
EPS:
0.0763
Net Cash Flow:
$-1.47M
1W Performance:
-8.61%
1M Performance:
-8.61%
6M Performance:
-8.61%
1Y Performance:
-8.61%
1-Day Range:
$9.85
$9.99
1-Week Range:
$9.85
$9.99
52-Week Range:
$9.85
$9.99
Twelve Seas Investment Co II Stock (TWLV) Company Profile
Name
Twelve Seas Investment Co II
Sector
Industry
Phone
323 667 3211
Address
228 Park Avenue South, Suite 89898, New York
Compare TWLV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TWLV
Twelve Seas Investment Co II
|
9.87 | 111.75M | 0 | 3.55M | -1.47M | 0.0763 |
|
XXI
Twenty One Capital Inc
|
9.20 | 3.29B | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
8.99 | 2.61B | 3.13B | -174.20M | -111.20M | -0.6937 |
|
CCCX
Churchill Capital Corp X
|
18.80 | 1.01B | 0 | 0 | 0 | 0.00 |
|
DMII
Drugs Made In America Acquisition Ii Corp
|
9.92 | 650.18M | 0 | 0 | 0 | 0.00 |
|
BCSS
Bain Capital Gss Investment Corp
|
10.15 | 593.64M | 0 | 0 | 0 | 0.00 |
Twelve Seas Investment Co II Stock (TWLV) Latest News
Twelve Seas Investment Company III Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing January 9, 2026 - TradingView — Track All Markets
Twelve Seas Investment Co III Announces Separate Trading of Shares and Rights - TradingView — Track All Markets
Nasdaq stock bundle splits so traders can buy its pieces alone - Stock Titan
SAMstream Launches AI Platform to Help Organizations of All Sizes Find and Bid on Government Contracts - The Manila Times
Terns Pharmaceuticals to Highlight 2026 Priorities and Program Milestones at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Sanara MedTech Inc. Receives Innovative Technology Contract from Vizient for BIASURGE® Advanced Surgical Solution - The Manila Times
Terrestrial Energy to Participate in the 28th Annual Needham Growth Conference - The Manila Times
Bitfarms to Present at Needham Growth Conference in NYC - The Manila Times
RAPT Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Constellation Brands Reports Third Quarter Fiscal 2026 Financial Results - The Manila Times
Ultragenyx to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Sutro Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Definitive Healthcare to Present at the 28th Annual Needham Growth Conference - The Manila Times
iMDx Announces 'JPM Week” and 'BTIG Snowbird” Conference Participation - The Manila Times
Krystal Biotech to Announce Interim Clinical Update from Highest Dose Cohort of Phase 1 CORAL-1 Study Evaluating KB407 in Patients with Cystic Fibrosis - The Manila Times
Crane NXT to Participate in the CJS Securities 26th Annual New Ideas for the New Year Conference - The Manila Times
Ethan Allen Announces Release Date for its Fiscal 2026 Second Quarter Results - The Manila Times
Annexon Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - The Manila Times
LifeVantage Appoints Seasoned Technology Executive Mike Edwards as Chief Technology Officer to Drive Digital Innovation - The Manila Times
BioStem Technologies Comments on Withdrawal of CMS CY 2026 Final Medicare Reimbursement Rule for Skin Substitutes - The Manila Times
Turn Therapeutics Appoints Martin Dewhurst to its Board of Directors - The Manila Times
Abivax Provides 2026 Corporate Outlook - The Manila Times
Phathom Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - The Manila Times
Viper Energy, Inc., a Subsidiary of Diamondback Energy, Inc., Schedules Fourth Quarter 2025 Conference Call for February 24, 2026 - The Manila Times
Diamondback Energy, Inc. Schedules Fourth Quarter 2025 Conference Call for February 24, 2026 - The Manila Times
Genelux Corporation Announces Proposed Public Offering of Common Stock - The Manila Times
Republic Power Group Limited Announces Receipt of a Bid Deficiency Notice from Nasdaq - The Manila Times
Crane Harbor Acquisition Corp. II Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing January 12, 2026 - The Manila Times
Immuneering Announces Exceptional 64% Overall Survival At 12 Months in First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP - The Manila Times
Amlan International Brings Gut Health and Feed Efficiency Innovation to IPPE 2026 - The Manila Times
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF - The Manila Times
Kiniksa Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Bahamas.com Wins Caribbean’s Best Tourism Authority Website 2025 at World Travel Tech Awards - The Manila Times
Twelve Seas Investment Co III completes $172.5 million IPO and private placement By Investing.com - Investing.com
Twelve Seas Investment Co III Completes IPO and Private Placement - TradingView — Track All Markets
Free cash flow per share of Twelve Seas Investment Company III Units Cons of 1 Shs -A- + 1/10 Rt – BOATS:TWLVU - TradingView — Track All Markets
Return on equity % of Twelve Seas Investment Company III Units Cons of 1 Shs -A- + 1/10 Rt – BOATS:TWLVU - TradingView — Track All Markets
Twelve Seas Investment Company III Units Cons of 1 Shs -A- + 1/10 Rt Earnings and Revenue – BOATS:TWLVU - TradingView — Track All Markets
Twelve Seas Investment Company III Units Cons of 1 Shs -A- + 1/10 Rt - TradingView — Track All Markets
Discontinued operations of Twelve Seas Investment Company III Units Cons of 1 Shs -A- + 1/10 Rt – BOATS:TWLVU - TradingView — Track All Markets
Twelve Seas Investment Company III Units Cons of 1 Shs -A- + 1/10 Rt Balance Sheet – BOATS:TWLVU - TradingView — Track All Markets
Twelve Seas Investment Company III Units Cons of 1 Shs -A- + 1/10 Rt Income Statement – BOATS:TWLVU - TradingView — Track All Markets
Twelve Seas Investment Company III Units Cons of 1 Shs -A- + 1/10 Rt Cash Flow – BOATS:TWLVU - TradingView — Track All Markets
Enterprise value of Twelve Seas Investment Company III Units Cons of 1 Shs -A- + 1/10 Rt – BOATS:TWLVU - TradingView — Track All Markets
Twelve Seas Investment Company III Units Cons of 1 Shs -A- + 1/10 Rt Statistics – BOATS:TWLVU - TradingView — Track All Markets
Twelve Seas Investment Company III Units Cons of 1 Shs -A- + 1/10 Rt Financial Statements – BOATS:TWLVU - TradingView — Track All Markets
TWLVR Price History for Twelve Seas Investment Company Rights Stock - Barchart.com
Working capital per share of Twelve Seas Investment Company III Units Cons of 1 Shs -A- + 1/10 Rt – NASDAQ:TWLVU - TradingView — Track All Markets
Total debt per share of Twelve Seas Investment Company III Units Cons of 1 Shs -A- + 1/10 Rt – NASDAQ:TWLVU - TradingView — Track All Markets
Twelve Seas Investment Co II Stock (TWLV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.29%
6.10%
Cap:
|
Volume (24h):